PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT 2.1 Preface 2.2 Preface 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE Market ecosystem Market characteristics Market segmentation analysis PART 04: MARKET SIZING Market definition Market sizing 2018 Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition PART 06: MARKET SEGMENTATION BY END-USER Market segmentation by end-user Comparison by end-user Hospitals, clinics, and physicians' offices - Market size and forecast 2018-2023 ASCs - Market size and forecast 2018-2023 Market opportunity by end-user PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE Geographic segmentation Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES Market drivers Market challenges PART 11: MARKET TRENDS Growing focus on advances in endoscopic clips Adoption of business strategies by vendors to boost sales Funding for GI research studies PART 12: VENDOR LANDSCAPE Overview Landscape disruption Competitive scenario PART 13: VENDOR ANALYSIS Vendors covered Vendor classification Market positioning of vendors B. Braun Melsungen AG Boston Scientific Corp. CONMED Corp. Johnson & Johnson Services Inc. Olympus Corp. PART 14: APPENDIX Research methodology List of abbreviations Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Product overview Exhibit 02: Global medical devices market Exhibit 03: Segments of global medical devices market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: End-user - Market share 2018-2023 (%) Exhibit 18: Comparison by end-user Exhibit 19: Hospitals, clinics, and physicians' offices - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Clinical trials for gastric cancer conducted by hospitals Exhibit 21: Hospitals, clinics, and physicians' offices - Year-over-year growth 2019-2023 (%) Exhibit 22: ASCs - Market size and forecast 2018-2023 ($ millions) Exhibit 23: GI procedures performed in ASC and hospital in-patient setting in 2014 in the US Exhibit 24: ASCs - Year-over-year growth 2019-2023 (%) Exhibit 25: Market opportunity by end-user Exhibit 26: Customer landscape Exhibit 27: Market share by geography 2018-2023 (%) Exhibit 28: Geographic comparison Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 30: North America - Year-over-year growth 2019-2023 (%) Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Europe - Year-over-year growth 2019-2023 (%) Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 34: Asia - Year-over-year growth 2019-2023 (%) Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 36: ROW - Year-over-year growth 2019-2023 (%) Exhibit 37: Key leading countries Exhibit 38: Market opportunity Exhibit 39: Product launches and market impact analysis Exhibit 40: Average cost of GI cancer diagnostic and treatment procedures in US and European countries Exhibit 41: Product recalls and market impact analysis Exhibit 42: Impact of drivers and challenges Exhibit 43: Business strategy and market impact analysis Exhibit 44: Vendor landscape Exhibit 45: Landscape disruption Exhibit 46: Vendors covered Exhibit 47: Vendor classification Exhibit 48: Market positioning of vendors Exhibit 49: B. Braun Melsungen AG - Vendor overview Exhibit 50: B. Braun Melsungen AG - Product segments Exhibit 51: B. Braun Melsungen AG - Organizational developments Exhibit 52: B. Braun Melsungen AG - Geographic focus Exhibit 53: B. Braun Melsungen AG - Segment focus Exhibit 54: B. Braun Melsungen AG - Key offerings Exhibit 55: B. Braun Melsungen AG - Key customers Exhibit 56: Boston Scientific Corp. - Vendor overview Exhibit 57: Boston Scientific Corp. - Business segments Exhibit 58: Boston Scientific Corp. - Organizational developments Exhibit 59: Boston Scientific Corp. - Geographic focus Exhibit 60: Boston Scientific Corp. - Segment focus Exhibit 61: Boston Scientific Corp. - Key offerings Exhibit 62: Boston Scientific Corp. - Key customers Exhibit 63: CONMED Corp. - Vendor overview Exhibit 64: CONMED Corp. - Business segments Exhibit 65: CONMED Corp. - Organizational developments Exhibit 66: CONMED Corp. - Geographic focus Exhibit 67: CONMED Corp. - Segment focus Exhibit 68: CONMED Corp. - Key offerings Exhibit 69: CONMED Corp. - Key customers Exhibit 70: Johnson & Johnson Services Inc. - Vendor overview Exhibit 71: Johnson & Johnson Services Inc. - Business segments Exhibit 72: Johnson & Johnson Services Inc. - Organizational developments Exhibit 73: Johnson & Johnson Services Inc. - Geographic focus Exhibit 74: Johnson & Johnson Services Inc. - Segment focus Exhibit 75: Johnson & Johnson Services Inc. - Key offerings Exhibit 76: Johnson & Johnson Services Inc. - Key customers Exhibit 77: Olympus Corp. - Vendor overview Exhibit 78: Olympus Corp. - Business segments Exhibit 79: Olympus Corp. - Organizational developments Exhibit 80: Olympus Corp. - Geographic focus Exhibit 81: Olympus Corp. - Segment focus Exhibit 82: Olympus Corp. - Key offerings Exhibit 83: Olympus Corp. - Key customers Exhibit 84: Validation techniques employed for market sizing Exhibit 85: Definition of market positioning of vendors

B. Braun Melsungen AG, Boston Scientific Corp., CONMED Corp., Johnson & Johnson Services Inc., and Olympus Corp.